Related Experiment Videos
Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex
David G Winkler1, Changpu Yu, James C Geoghegan
1Department of Gene Function and Target Validation, Celltech R&D, Inc., Bothell, WA 98021, USA.
The Journal of Biological Chemistry
|June 17, 2004
Summary
Noggin and sclerostin directly bind, forming a complex that regulates bone morphogenetic protein (BMP) activity. This interaction fine-tunes BMP signaling, crucial for maintaining bone homeostasis.
Area of Science:
- Biochemistry
- Molecular Biology
- Bone Biology
Background:
- Noggin and sclerostin are bone morphogenetic protein (BMP) antagonists.
- Their interactions and roles in modulating BMP activity are not fully understood.
Purpose of the Study:
- To investigate the interaction between noggin and sclerostin.
- To elucidate the functional consequences of this interaction on BMP signaling.
Main Methods:
- Recombinant protein binding assays to determine affinity.
- Analysis of naturally expressed noggin and sclerostin in rat osteosarcoma cells (ROS 17/2.8).
- BMP binding competition assays.
Main Results:
- High-affinity binding between recombinant noggin and sclerostin (K(D) = 2.92 nm).
- Confirmation of noggin-sclerostin complex formation with naturally expressed proteins.
- The complex competed with BMP binding and attenuated antagonist activity.
Conclusions:
- Noggin and sclerostin form a complex that directly regulates BMP activity.
- This interaction provides a novel mechanism for fine-tuning BMP signaling in bone homeostasis.
- Co-localized expression of BMP antagonists offers a new paradigm for biological regulation.